Switching to Insulin Degludec from Insulin Glargine U100 Improves Glycemic Control in People with Type 1 (T1D) or Type 2 diabetes (T2D) in a Real-World Setting

SOREN T. KNUDSEN; NIKOLAOS TENTOLOURIS; BERND SCHULTES; ANNUNZIATA LAPOLLA; MARKUS EIDENMUELLER; RUDOLF PRAGER; ANDREI-MIRCEA CATARIG; MICHAEL L. WOLDEN; THORSTEN SIEGMUND

doi:10.2337/db18-1014-p

Switching to Insulin Degludec from Insulin Glargine U100 Improves Glycemic Control in People with Type 1 (T1D) or Type 2 diabetes (T2D) in a Real-World Setting

Diabetes ◽

10.2337/db18-1014-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1014-P

Author(s):

SOREN T. KNUDSEN ◽

NIKOLAOS TENTOLOURIS ◽

BERND SCHULTES ◽

ANNUNZIATA LAPOLLA ◽

MARKUS EIDENMUELLER ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Glargine ◽

Real World ◽

Insulin Degludec ◽

Real World Setting

Download Full-text

Factors that Affect the Glycemic Control Achieved by Switching to Insulin Degludec/ Aspart in Insulin-Treated Patients with Type 1 and Type 2 Diabetes in a Real-World Setting: a Non-Interventional, Retrospective Cohort Study

Acta Endocrinologica (Bucharest) ◽

10.4183/aeb.2020.443 ◽

2020 ◽

Vol 16 (4) ◽

pp. 443-448

Author(s):

C Onder

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Glycemic Control ◽

Real World ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Insulin Degludec ◽

Real World Setting

Download Full-text

Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort Study

Diabetes Therapy ◽

10.1007/s13300-017-0297-9 ◽

2017 ◽

Vol 8 (5) ◽

pp. 1047-1055 ◽

Cited By ~ 3

Author(s):

Cheli Melzer Cohen ◽

Brian Larsen Thorsted ◽

Michael Lyng Wolden ◽

Gabriel Chodick ◽

Avraham Karasik

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Glycemic Control ◽

Real World ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Insulin Degludec ◽

Real World Setting

Download Full-text

Comparative clinical outcomes of insulin degludec and insulin glargine 300 U/mL after switching from other basal insulins in real‐world patients with type 1 and type 2 diabetes

Journal of Diabetes Investigation ◽

10.1111/jdi.13559 ◽

2021 ◽

Author(s):

Junko Oya ◽

Tomoko Nakagami ◽

Yukiko Hasegawa ◽

Aki Katamine ◽

Yuichiro Kondo ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Insulin Degludec

Download Full-text

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching From Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+ Subgroup Analyses

Diabetes ◽

10.2337/db18-1057-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1057-P

Author(s):

SEAN D. SULLIVAN ◽

TIMOTHY S. BAILEY ◽

RONAN ROUSSEL ◽

FANG L. ZHOU ◽

ZSOLT BOSNYAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Insulin Detemir ◽

Insulin Degludec ◽

Subgroup Analyses

Download Full-text

Clinical Research of Insulin Glargine U300 basal‐bolus therapy and Insulin Degludec/Aspart Co‐Formulation in Type 2 Diabetes Mellitus: A Real World Experience (CRIGDA Study)

International Journal of Clinical Practice ◽

10.1111/ijcp.14377 ◽

2021 ◽

Author(s):

Savas Volkan Kisioglu ◽

Ahmet Suat Demir ◽

Damla Tufekci ◽

Yasemin Emur Gunay ◽

Hulya Coskun ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Clinical Research ◽

Insulin Glargine ◽

Real World ◽

Insulin Degludec ◽

Basal Bolus

Download Full-text

Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.04.012 ◽

2019 ◽

Vol 43 (7) ◽

pp. 504-509.e1 ◽

Cited By ~ 2

Author(s):

Alexander Abitbol ◽

Ruth E. Brown ◽

Dishay Jiandani ◽

Luc Sauriol ◽

Ronnie Aronson

Keyword(s):

Type 2 Diabetes ◽

Health Outcomes ◽

Insulin Glargine ◽

Real World ◽

Diabetes Patient ◽

World Health ◽

Patient Registry

Download Full-text

Review for "Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: DELIVER Naïve D real‐world study"

10.1111/dom.13793/v1/review3 ◽

2019 ◽

Author(s):

Fernando Gomez-Peralta

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Real World ◽

Insulin Degludec

Download Full-text

Decision letter for "Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin‐Naïve Patients with Type 2 Diabetes after Failure of Oral Therapy in a Real World Setting"

10.1111/dom.13952/v3/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Real World ◽

Oral Therapy ◽

Real World Setting

Download Full-text

Review for "Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin‐Naïve Patients with Type 2 Diabetes after Failure of Oral Therapy in a Real World Setting"

10.1111/dom.13952/v1/review5 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Real World ◽

Oral Therapy ◽

Real World Setting

Download Full-text

Review for "Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin‐Naïve Patients with Type 2 Diabetes after Failure of Oral Therapy in a Real World Setting"

10.1111/dom.13952/v1/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Real World ◽

Oral Therapy ◽

Real World Setting

Download Full-text